The protective role of DPP4 inhibitors in atherosclerosis

Diabetes is a chronic non-communicable disease whose incidence continues to grow rapidly, and it is one of the most serious and critical public health problems. Diabetes complications, especially atherosclerosis-related chronic vascular complications, are a serious threat to human life and health. G...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of pharmacology 2020-05, Vol.875, p.173037-173037, Article 173037
Hauptverfasser:	Liu, Hengdao, Guo, Lingli, Xing, Junhui, Li, Peicheng, Sang, Haiqiang, Hu, Xiaofang, Du, Yunpeng, Zhao, Liangping, Song, Ruipeng, Gu, Heping
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Atherosclerosis - blood Atherosclerosis - etiology Atherosclerosis - pathology Atherosclerosis - prevention & control Blood Pressure - drug effects Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Diabetic chronic vascular complications Dipeptidyl Peptidase 4 - blood Dipeptidyl Peptidase 4 - metabolism Dipeptidyl-Peptidase IV Inhibitors - pharmacology Dipeptidyl-Peptidase IV Inhibitors - therapeutic use Disease Models, Animal DPP4 inhibitors Endothelial Cells - drug effects Endothelial Cells - pathology Endothelium, Vascular - cytology Endothelium, Vascular - drug effects Endothelium, Vascular - pathology Humans Lipid Metabolism - drug effects Lipids - blood Oxidative Stress - drug effects Protective role Risk Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!